Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Bioventus Inc. stock logo
BVS
Bioventus
$9.88
-0.7%
$12.87
$6.47
▼
$15.89
$832.50M0.66538,117 shs612,434 shs
Alpha Tau Medical Ltd. stock logo
DRTS
Alpha Tau Medical
$11.75
+3.9%
$13.84
$3.43
▼
$15.79
$1.06B1.28590,541 shs626,633 shs
Enovis Corporation stock logo
ENOV
Enovis
$25.44
-3.0%
$21.17
$16.70
▼
$31.67
$1.47B1.311.27 million shs1.22 million shs
Orchestra BioMed Holdings, Inc. stock logo
OBIO
Orchestra BioMed
$6.58
-6.0%
$6.00
$3.46
▼
$7.82
$404.34M0.56309,060 shs554,316 shs
Forget Nvidia, Meta, and Google. Here's The New Magnificent Seven. Cover

Discover the next wave of investment opportunities with our report, 7 Stocks That Will Be Magnificent in 2026. Explore companies poised to replicate the growth, innovation, and value creation of the tech giants dominating today's markets.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Bioventus Inc. stock logo
BVS
Bioventus
-6.36%-8.43%-28.71%-30.84%+47.99%
Alpha Tau Medical Ltd. stock logo
DRTS
Alpha Tau Medical
-5.65%-15.18%-13.43%-24.05%+207.93%
Enovis Corporation stock logo
ENOV
Enovis
-3.53%-5.08%+26.87%+0.02%-3.63%
Orchestra BioMed Holdings, Inc. stock logo
OBIO
Orchestra BioMed
-6.17%+13.82%+20.27%+30.60%+50.21%
CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Bioventus Inc. stock logo
BVS
Bioventus
$9.88
-0.7%
$12.87
$6.47
▼
$15.89
$832.50M0.66538,117 shs612,434 shs
Alpha Tau Medical Ltd. stock logo
DRTS
Alpha Tau Medical
$11.75
+3.9%
$13.84
$3.43
▼
$15.79
$1.06B1.28590,541 shs626,633 shs
Enovis Corporation stock logo
ENOV
Enovis
$25.44
-3.0%
$21.17
$16.70
▼
$31.67
$1.47B1.311.27 million shs1.22 million shs
Orchestra BioMed Holdings, Inc. stock logo
OBIO
Orchestra BioMed
$6.58
-6.0%
$6.00
$3.46
▼
$7.82
$404.34M0.56309,060 shs554,316 shs
Forget Nvidia, Meta, and Google. Here's The New Magnificent Seven. Cover

Discover the next wave of investment opportunities with our report, 7 Stocks That Will Be Magnificent in 2026. Explore companies poised to replicate the growth, innovation, and value creation of the tech giants dominating today's markets.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Bioventus Inc. stock logo
BVS
Bioventus
-6.36%-8.43%-28.71%-30.84%+47.99%
Alpha Tau Medical Ltd. stock logo
DRTS
Alpha Tau Medical
-5.65%-15.18%-13.43%-24.05%+207.93%
Enovis Corporation stock logo
ENOV
Enovis
-3.53%-5.08%+26.87%+0.02%-3.63%
Orchestra BioMed Holdings, Inc. stock logo
OBIO
Orchestra BioMed
-6.17%+13.82%+20.27%+30.60%+50.21%
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Bioventus Inc. stock logo
BVS
Bioventus
2.83
Moderate Buy$16.6068.02% Upside
Alpha Tau Medical Ltd. stock logo
DRTS
Alpha Tau Medical
2.67
Moderate Buy$18.2054.93% Upside
Enovis Corporation stock logo
ENOV
Enovis
2.75
Moderate Buy$38.6351.83% Upside
Orchestra BioMed Holdings, Inc. stock logo
OBIO
Orchestra BioMed
2.75
Moderate Buy$13.43104.08% Upside

Current Analyst Ratings Breakdown

Latest OBIO, DRTS, ENOV, and BVS Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
11/20/2026
Orchestra BioMed Holdings, Inc. stock logo
OBIO
Orchestra BioMed
Reiterated RatingBuy$11.00 ➝ $12.00
11/17/2026
Alpha Tau Medical Ltd. stock logo
DRTS
Alpha Tau Medical
Reiterated RatingBuy
11/17/2026
Alpha Tau Medical Ltd. stock logo
DRTS
Alpha Tau Medical
Reiterated RatingBuy$16.00
11/13/2026
Orchestra BioMed Holdings, Inc. stock logo
OBIO
Orchestra BioMed
Boost Price TargetBuy$10.00 ➝ $12.00
11/13/2026
Orchestra BioMed Holdings, Inc. stock logo
OBIO
Orchestra BioMed
Boost Price TargetBuy$10.00 ➝ $12.00
11/11/2026
Alpha Tau Medical Ltd. stock logo
DRTS
Alpha Tau Medical
UpgradeNeutral ➝ Overweight$8.00 ➝ $22.00
11/9/2026
Alpha Tau Medical Ltd. stock logo
DRTS
Alpha Tau Medical
UpgradeStrong Sell ➝ Hold
11/6/2026
Enovis Corporation stock logo
ENOV
Enovis
Lower Price TargetBuy$45.00 ➝ $42.00
11/6/2026
Enovis Corporation stock logo
ENOV
Enovis
Boost Price TargetOverweight$33.00 ➝ $37.00
11/5/2026
Enovis Corporation stock logo
ENOV
Enovis
Boost Price TargetBuy$34.00 ➝ $38.00
11/5/2026
Enovis Corporation stock logo
ENOV
Enovis
Boost Price TargetBuy$36.00 ➝ $42.00
(Data available from 11/20/2023 forward. View 10+ years of historical ratings with our analyst ratings screener.)
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Bioventus Inc. stock logo
BVS
Bioventus
$585.64M1.42$1.19 per share8.33$3.46 per share2.86
Alpha Tau Medical Ltd. stock logo
DRTS
Alpha Tau Medical
N/AN/AN/AN/A$0.88 per shareN/A
Enovis Corporation stock logo
ENOV
Enovis
$2.25B0.65$25.19 per share1.01$25.92 per share0.98
Orchestra BioMed Holdings, Inc. stock logo
OBIO
Orchestra BioMed
$33.48M12.08N/AN/A$0.13 per share50.62
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Bioventus Inc. stock logo
BVS
Bioventus
$22.73M$0.8012.3511.231.369.78%26.31%10.13%N/A
Alpha Tau Medical Ltd. stock logo
DRTS
Alpha Tau Medical
-$42.63M-$1.04N/AN/AN/AN/A-138.12%-81.68%N/A
Enovis Corporation stock logo
ENOV
Enovis
-$1.18B-$9.21N/A8.90N/A-22.86%13.23%5.19%N/A
Orchestra BioMed Holdings, Inc. stock logo
OBIO
Orchestra BioMed
-$52.70M-$0.75N/AN/AN/A-182.50%-186.93%-51.90%N/A

Latest OBIO, DRTS, ENOV, and BVS Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
11/10/2026Q3 2026
Orchestra BioMed Holdings, Inc. stock logo
OBIO
Orchestra BioMed
-$0.4007-$0.30+$0.1007-$0.30$0.13 million$0.09 million
11/5/2026Q3 2026
Enovis Corporation stock logo
ENOV
Enovis
$0.7670$0.88+$0.1130$0.06$557.12 million$558.73 million
11/2/2026Q3 2026
Bioventus Inc. stock logo
BVS
Bioventus
$0.17$0.17N/A$0.08N/A$142.44 million
CompanyAnnual PayoutDividend Yield5-Year Annualized Dividend GrowthPayout RatioYears of Consecutive Growth
Bioventus Inc. stock logo
BVS
Bioventus
N/AN/AN/AN/AN/A
Alpha Tau Medical Ltd. stock logo
DRTS
Alpha Tau Medical
N/AN/AN/AN/AN/A
Enovis Corporation stock logo
ENOV
Enovis
N/AN/AN/AN/AN/A
Orchestra BioMed Holdings, Inc. stock logo
OBIO
Orchestra BioMed
N/AN/AN/AN/AN/A
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Bioventus Inc. stock logo
BVS
Bioventus
0.72
1.68
1.16
Alpha Tau Medical Ltd. stock logo
DRTS
Alpha Tau Medical
0.15
11.09
7.79
Enovis Corporation stock logo
ENOV
Enovis
0.82
2.15
1.08
Orchestra BioMed Holdings, Inc. stock logo
OBIO
Orchestra BioMed
4.58
7.25
7.24

Institutional Ownership

CompanyInstitutional Ownership
Bioventus Inc. stock logo
BVS
Bioventus
62.94%
Alpha Tau Medical Ltd. stock logo
DRTS
Alpha Tau Medical
2.65%
Enovis Corporation stock logo
ENOV
Enovis
98.45%
Orchestra BioMed Holdings, Inc. stock logo
OBIO
Orchestra BioMed
53.20%

Insider Ownership

CompanyInsider Ownership
Bioventus Inc. stock logo
BVS
Bioventus
33.50%
Alpha Tau Medical Ltd. stock logo
DRTS
Alpha Tau Medical
39.50%
Enovis Corporation stock logo
ENOV
Enovis
2.90%
Orchestra BioMed Holdings, Inc. stock logo
OBIO
Orchestra BioMed
7.50%
CompanyEmployeesShares OutstandingFree FloatOptionable
Bioventus Inc. stock logo
BVS
Bioventus
96084.26 million56.03 millionOptionable
Alpha Tau Medical Ltd. stock logo
DRTS
Alpha Tau Medical
12190.33 million54.65 millionOptionable
Enovis Corporation stock logo
ENOV
Enovis
7,80257.69 million56.02 millionOptionable
Orchestra BioMed Holdings, Inc. stock logo
OBIO
Orchestra BioMed
8661.45 million56.84 millionOptionable

Recent News About These Companies

HC Wainwright Expects Stronger Earnings for Orchestra BioMed
Equities Analysts Set Expectations for OBIO FY2026 Earnings
Orchestra BioMed Prices $75 Million Common Stock Offering
Orchestra BioMed Announces Pricing of Public Offering

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

View All Headlines
Bioventus stock logo

Bioventus NASDAQ:BVS

$9.88 -0.07 (-0.70%)
Closing price 04:00 PM Eastern
Extended Trading
$9.90 +0.01 (+0.15%)
As of 04:54 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Bioventus Inc. a medical device company, focuses on developing and commercializing clinically treatments that engage and enhance the body's natural healing process in the United States and internationally. The company's portfolio of products includes pain treatments, which comprise non-surgical joint pain injection therapies, as well as peripheral nerve stimulation products. Its surgical solutions include bone graft substitutes to fuse and grow bones, enhance results following spinal and other orthopedic surgeries; and ultrasonic medical devices for the use in precise bone sculpting, remove tumors, and tissue debridement. The company's restorative therapies comprise an ultrasonic bone healing system for fracture care; skin allografts; and products that are used to support healing of chronic wounds, as well as advanced rehabilitation devices designed to help patients regain leg or hand function. It serves physicians spanning the orthopedic continuum, including sports medicine, total joint reconstruction, hand and upper extremities, foot and ankle, podiatric surgery, trauma, spine, and neurosurgery in the physician's office or clinic, ambulatory surgical centers, or in the hospital setting. The company was founded in 2011 and is headquartered in Durham, North Carolina.

Alpha Tau Medical stock logo

Alpha Tau Medical NASDAQ:DRTS

$11.75 +0.44 (+3.86%)
Closing price 03:58 PM Eastern
Extended Trading
$11.63 -0.12 (-1.00%)
As of 05:37 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Alpha Tau Medical Ltd., a clinical-stage oncology therapeutics company, engages in research, development, and commercialization of diffusing alpha-emitters radiation therapy (Alpha DaRT) for the treatment of solid cancer In Israel and the United States. Its Alpha-DaRT technology used in clinical trials for skin, oral, pancreatic, prostate, and breast cancers; and preclinical studies for brain, hepatic cell carcinoma, glioblastoma multiforme, lung cancer, and others. The company was incorporated in 2015 and is headquartered in Jerusalem, Israel.

Enovis stock logo

Enovis NYSE:ENOV

$25.44 -0.79 (-3.01%)
Closing price 03:59 PM Eastern
Extended Trading
$25.46 +0.02 (+0.10%)
As of 05:31 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Enovis Corporation operates as a medical technology company focus on developing clinically differentiated solutions worldwide. It also manufactures and distributes medical devices which are used for reconstructive surgery, rehabilitation, pain management, and physical therapy. The company operates through Prevention and Recovery, and Reconstructive segments. Its Prevention and Recovery segment offers orthopedic solutions and recovery sciences including rigid and soft orthopedic bracing, hot and cold therapy, bone growth stimulators, vascular therapy systems and compression garments, therapeutic shoes and inserts, electrical stimulators management, and physical therapy products which are used by orthopedic specialists, surgeons, primary care physicians, pain management specialists, physical therapists, podiatrists, chiropractors, athletic trainers, and other healthcare professionals. The company's Reconstructive segment operates surgical implant business, which includes a suite of reconstructive joint products for the hip, knee, shoulder, elbow, foot, ankle, and finger, as well as surgical productivity tools. The company distributes its products through independent distributors and directly under the ESAB and DJO brands. Enovis Corporation was formerly known as Colfax Corporation. The company was founded in 1995 and is headquartered in Wilmington, Delaware.

Orchestra BioMed stock logo

Orchestra BioMed NASDAQ:OBIO

$6.58 -0.42 (-6.00%)
Closing price 04:00 PM Eastern
Extended Trading
$6.57 -0.01 (-0.15%)
As of 04:54 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Orchestra BioMed Holdings, Inc. operates as a biomedical innovation company. The company's flagship product candidates include BackBeat Cardiac Neuromodulation Therapy (CNT) for the treatment of hypertension (HTN); and Virtue Sirolimus AngioInfusion Balloon (SAB) for the treatment of atherosclerotic artery disease. Its products also comprise FreeHold devices and minimally invasive surgery devices. The company has a collaboration agreement with Medtronic, Inc. for the development and commercialization of BackBeat CNT for the treatment of HTN in patients indicated for a cardiac pacemaker; and a strategic collaboration with Terumo Medical Corporation for the development and commercialization of Virtue SAB for the treatment of coronary and peripheral artery disease. Orchestra BioMed Holdings, Inc. is based in New Hope, Pennsylvania.